Evidence map›Paper›PMID 23433867›Full record

ArticleThe Journal of hospital infection2013

Defining acute renal dysfunction as a criterion for the severity of Clostridium difficile infection in patients with community-onset vs hospital-onset infection.

D N Shah, N S Bhatt, J K Welch, H L Koo, K W Garey

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in The Journal of hospital infection, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Guideline
  2. Defining FulminantOpen forum infectious diseases · 2025
    Article
  3. Article
  4. Article
  5. Journal of clinical medicine · 2021
    Review
  6. Assessment of Kidney Injury as a Severity Criteria forOpen forum infectious diseases · 2020
    Article
  7. South African Society of Clinical MicrobiologySouthern African journal of infectious diseases · 2020
    Article
  8. Metronidazole therapy as initial treatment ofEpidemiology and infection · 2019
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

D N ShahUniversity of Houston, College of Pharmacy, Houston, TX 77030, USA.
N S Bhatt
J K Welch
H L Koo
K W Garey
The University of Texas Health Science Center at Houston · USSt. Luke's Episcopal Hospital · USUniversity of Houston · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Host Genetic Susceptibility and Immune Responses to Norovirus InfectionsK23DK084513 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI KOO, HOONMO LEE · 2009 to 2012
$699k
NIDDK NIH HHS K23 DK084513NIDDK NIH HHS P30 DK056338
6 · The paper itself

Abstract

backgroundAcute renal dysfunction can be used to define severe Clostridium difficile infection (CDI). The Society for Healthcare Epidemiology of America (SHEA) and Infectious Disease Society of America (IDSA) guidelines define acute renal dysfunction as serum creatinine (SrCr) ≥1.5 times the premorbid level.

aimTo determine the ability to assess premorbid SrCr in hospitalized patients with CDI, stratified into community-onset CDI (CO-CDI) and hospital-onset CDI (HO-CDI); and to evaluate differing definitions for premorbid SrCr as a criterion for acute renal dysfunction.

methodsHospitalized patients with CDI were stratified into CO-CDI and HO-CDI. The ability to assess premorbid SrCr was determined, and the incidence of acute renal dysfunction and the severity of CDI were compared using varying definitions of premorbid SrCr.

findingsIn total, 293 patients with CDI were evaluated; of these, 135 (46%) had CO-CDI and 158 (54%) had HO-CDI. Premorbid SrCr data were not available for 37 (27%) patients with CO-CDI and one (<1%) patient with HO-CDI (P < 0.0001). Depending on the definition of premorbid SrCr used, acute renal dysfunction ranged from 17% to 24% for patients with CO-CDI (P = 0.26), and from 13% to 14% for HO-CDI (P = 0.81). The severity of CDI could not be determined for 43 out of 293 (15%) patients, primarily due to the lack of premorbid SrCr data (N = 38).

conclusionAssessment of acute renal dysfunction and the severity of CDI was not possible for many patients with CO-CDI using the current SHEA/IDSA guidelines. Given the increasing incidence of CO-CDI, an alternative definition of acute renal dysfunction may be required.

Indexed as

AdultAgedAged, 80 and overClostridium InfectionsCohort StudiesCommunity-Acquired InfectionsCreatinineCross InfectionFemaleHumansMaleMiddle AgedProspective StudiesRenal InsufficiencySerumCreatinine

Identifiers

PMID23433867
PMCPMC3984400
OpenAlexW2076595731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.